Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹217.58
Market cap: ₹2,683 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -79.4×Sector 50.4×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Production Started 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Aug 2026 17:09 IST BSE

Earnings Call

Hikal Earnings Call Transcript: Key Takeaways

Hikal reported Q1 FY27 revenue of Rs 403 Cr with 9.2% EBITDA margin. Results show recovery post-regulatory disruption, driven by Pharma and Animal Health scaling.

Call: Guides 15% growth

Open call summary → Read the filing ↗

6 Aug 2026 16:25 IST BSE

Earnings Call

Hikal Investor Presentation: Key Takeaways

Hikal reported Q1FY27 revenue of ₹403 Cr, up 6% YoY. Focus remains on pharma remediation and commissioning the Panoli facility for Personal Care.

Open call summary → Read the filing ↗